1
Discovery
Patient Population Analysis
Discovery
Clinical Development
Launch
Growth & Maurity
1 Discovery
Patient Population Analysis
Evidence Generation
2 Clinical Development
Trial Design & Optimization
Criteria for Community Adoption
Site Selection & Activation
Treatment Dispensation & Monitoring
KOL Engagement
3 Launch
Go-to-Market & Contracting Strategies
Provider Education & Engagement
Market Access
Access & Adherence Support
4 Growth & Maturity
Adoption Monitoring & Influencer Identification
Provider Insights
Decision Support
Scroll to start or jump to a section below
We offer a comprehensive suite of solutions that can shape the entire oncology drug development cycle.
Learn how we support discovery, clinical development, launch and growth strategies through our businesses as highlighted in this interactive journey.
MENU
Businesses
One Oncology
Patient’s Journey
of Hope
Oncology Drug
Development Journey
CLOSE
2
Clinical Development
Evidence Generation
Trial Design & Optimization
Criteria for Community Adoption
Site Selection & Activation
Treatment Dispensation & Monitoring
KOL Engagement
3
Launch
Go-to-Market & Contracting Strategies
Provider Education & Engagement
Market Access
Access & Adherence Support
4
Growth & Maturity
Adoption Monitoring & Influencer Identification
Provider Insights
Decision Support
Through Ontada, we provide a comprehensive dataset of clinical and multiomic data to support discovery activities such as mechanism insights, patient analysis, biomarker and resistance exploration, model development and drug optimization.
Developing a new drug requires an understanding of unmet needs so novel targets can be identified and clinical development prioritized.
Patient Population Analysis
Visit Ontada
Ontada accelerates life science research and provider channels to enable engagement and insights.
About Ontada
Ontada's real-world oncology data represents over 2.4 million cancer patient records available for research across more than 80 tumor types derived largely from community settings.
FACT
Through Ontada, Genospace and Sarah Canon Research Institute (SCRI), we offer robust data and analytics to support evidence-informed decisions.
Integrating real-world evidence (RWE) and traditional trial data into evidence strategies strengthens clinical development and product launch programs.
Evidence Generation
Visit Genospace
Genospace innovates precision medicine to improve patient outcomes by enabling clinical trial matching.
About Genospace
SCRI enrolls more than 3,100 patients in treatment clinical trials each year.
FACT
Read More
Bridging the Gaps in Patient Care
Insights from the 2025 CoverMyMeds Medication Access Report
OUR STORIES
Visit McKesson Compile
McKesson Compile helps biopharma companies develop and commercialize life-changing therapies through premier data and analytics.
About McKesson Compile
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
FACT
Embedding real-world data into clinical trial design provides access to information from representative populations.
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Trial Design & Optimization
Visit SCRI
SCRI advances the field of cancer research through clinical trials.
About Sarah Canon Research Institute (SCRI)
Sarah Cannon Research Institute is one of the world’s leading oncology research organizations conducting community-based clinical trials.
We have conducted more than 800 first-in-human clinical trials since our inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.
At Sarah Cannon Research Institute, we are revolutionizing cancer research by strategically selecting and activating high-quality clinical trial sites.
Our Accelero operations model maximizes time, resources and funds, enabling faster trial activation, patient enrollment and data provision.
By integrating just-in-time site activation, we ensure trials are not only efficient but also accessible, aligning patient needs with the latest therapeutic advancements.
Our partnership with Genospace and Sarah Cannon Research Institute’s Personalized Medicine services boosts trial enrollments by 50% and provides real time insights in order to select the right sites for the right trial.
With The US Oncology Network's support of over 600 sites in 31 states, alongside SCRI’s clinical research at more than 250 locations across 24 states, we are broadening the reach and enhancing the effectiveness of clinical trials, making them more accessible to eligible patients.
Together, we are advancing clinical trials and delivering hope to a wider array of communities.
Thank you for trusting Sarah Cannon Research Institute as your partner in this vital journey.
View Transcript
Strategic Selection and Activation of High-Quality Clinical Trial Sites
Read by Dee Anna Smith, CEO, SCRI
Visit The US Oncology Network
The US Oncology Network shapes the future of cancer care, close to home.
About The US Oncology Network
Addressing key clinical, reimbursement and operational requirements helps to ensure the safety and adoption within community healthcare settings. We finalize trial protocols with SCRI and The US Oncology Network.
Criteria for Community Adoption
SCRI and Genospace have facilitated an increase in interventional trial enrollments by more than 50% among the research sites utilizing the platform.
The US Oncology Network supports more than 600 sites of care across 31 states, and SCRI offers clinical research through more than 250 locations across 24 states.
FACT
Identifying high-quality sites maximizes the time, resources and funds for each clinical trial.
SCRI’s scaled seamless operations model, Accelero, enhances connectivity to research sites which enables SCRI to activate trials faster, enroll patients faster and provide critical data faster.
We also leverage Genospace to provide real-time insights into site activation, potential participant matches and enrollment progress.
We can expand the reach and effectiveness of clinical trials by opening new sites around eligible patients with SCRI and The US Oncology Network.
Site Selection
& Activation
Visit Clinical Research Services
CRS and CTS address the complexities of clinical trial logistics through drug access, pharmacy and distribution services.
About Clinical Research Services (CRS) and Clinical Trial Solutions (CTS)
Managing clinical trial logistics efficiently and securely requires a deep understanding of trial specifics.
We support sponsor-led clinical trials by offering logistical expertise, including drug access, pharmacy and distribution services, through Clinical Research Services and Clinical Trial Solutions.
Our Investigational Products Center in collaboration with SCRI sites, provides controlled delivery and management of investigational products and lab kits to safely store and deliver therapies to clinical trial sites and, in some cases, directly to patients participating in clinical trials from home.
Treatment Dispensation & Monitoring
Read More
Delivering on
Innovative Medical Breakthroughts
OUR STORIES
Identifying Key Opinion Leaders (KOLs) for their expert insights builds credibility within the medical community.
McKesson Compile helps to identify KOLs through prescribing and behavioral data. Through Ontada we engage physician leaders to interpret data, support real-world research, and ensure scientific integrity.
KOL Engagement
Visit InspiroGene by McKesson
InspiroGene by McKesson guides and supports the commercialization of cell and gene therapies.
About InspiroGene by McKesson
Developing comprehensive customer master data helps to lay the groundwork for targeted marketing efforts.
Ontada provides oncology electronic medical record data reflective of standard of care providing insights into physician level testing and treatment behavior to understand market trends and guide brand strategy.
McKesson Compile supports sales force strategy creation and go-to-market strategy development through prescriber and patient journey data.
To enhance drug adoption, we develop contracting strategies with McKesson Group Purchasing Organizations (Unity and Onmark).
The cell and gene therapy (CGT) commercialization landscape is complex. Through InspiroGene by McKesson, we offer manufacturers real-time solutions that leverage industry-leading third-party logistics, specialty distribution, specialty pharmacy and a CGT-focused patient HUB to reduce complexities, improve time to treatment and help CGTs realize their full potential. Through collaboration with The US Oncology Network and Sarah Cannon Research Institute, InspiroGene helps to expand CGT care into the community setting.
Go-to-Market & Contracting Strategies
Ontada Learn provides over 630,000 physician engagements
per year.
FACT
We leverage Ontada to share RWE with providers and convey the value of new therapies.
Provider Education and Engagement
Visit McKesson Specialty Distribution
McKesson Specialty Distribution helps specialty providers run successful businesses by clearing the path so they can focus on patient care.
About McKesson Specialty Distribution
Biologics by McKesson offers more than 200 oncology and rare disease therapies.
McKesson Third-Party Logistics (3PL) utilizes more than 1.5M sq. ft across core distribution centers to support specific therapy needs.
FACT
Distributing therapies through our distribution network inclusive of McKesson Specialty Distribution, Biologics by McKesson and McKesson Third-Party Logistics (3PL), ensures the safe, accurate and timely delivery of therapies to patients.
Market Access
Visit Biologics by McKesson
Biologics by McKesson delivers personalized care as an independent specialty pharmacy.
About Biologics by McKesson
Visit McKesson 3PL
McKesson 3PL ensures lifesaving therapies arrive safely, efficiently and on time.
About McKesson Third Party Logistics (3PL)
At McKesson, we are uniquely equipped to support biopharma customers’ clinical and commercial needs, particularly in oncology.
We understand the complexities of the oncology drug lifecycle and help our partners identify and solve complex problems, accelerate drug development, scale their commercialization efforts, and drive continued growth.
Our commercialization expertise spans healthcare policy and regulation, supply chain and distribution, patient support, and commercial evidence and insights.
We use our deep bench of knowledge to serve as advisors and thought partners to understand market trends, guide brand strategy, enhance drug adoption, reduce logistical complexities, improve time to treatment, and ensure therapies reach their full potential.
Our approaches aim to convey the value of new therapies to providers as well as help patients overcome barriers to access and adherence.
Together, we are advancing cancer care and delivering hope to patients in need.
Thank you for trusting McKesson as your partner in this vital journey.
View Transcript
McKesson's Expertise in Commercialization and Patient Support
Read by Ramesh Srinivasan, SVP and Chief Strategy and Transformation Officer for U.S. Pharmaceutical
Visit CoverMyMeds
CoverMyMeds focuses on overcoming barriers to medication access and affordability for patients throughout every step of their journey.
About CoverMyMeds
CoverMyMeds has saved patients more than $8.8 billion on specialty and brand medications.
FACT
Overcoming barriers to patient access and adherence requires care and cost management solutions.
We offer specialty pharmacy and care management programs through Biologics by McKesson and hub services and copay assistance options through CoverMyMeds.
Additionally, we assist in refining access strategies by monitoring patient cost and formulary access with McKesson Compile.
Access & Adherence Support
McKesson Compile captures claims from all parts of Medicare data (Parts A, B, C, D)
FACT
Tracking adoption and analyzing prescriber data informs strategic marketing initiatives.
We provide detailed utilization reports through Ontada and identify key prescribers and influencers with data from McKesson Compile.
Adoption Monitoring & Influencer Identification
We facilitate continued provider engagement opportunities through Ontada, manage ongoing contracting with McKesson Group Purchasing Strategies (Unity and Onmark) and monitor value-based care programs within The US Oncology Network.
Provider Insights
Read More
30 Years of Patient Empowerment: Biologics’ Journey
FEATURED
We deliver actionable insights through Ontada, Biologics by McKesson, CoverMyMeds, McKesson Compile and McKesson Group Purchasing Strategies (Unity and Onmark) to support ongoing marketing strategies.
Decision Support
Whether it’s designing clinical trials using RWE or setting a go-to-market strategy, we are here to partner with you.
We’re committed to always advancing promising new therapies, so more patients get the care they need.
VISIT McKESSON.COM
EXPLORE THE PATIENT JOURNEY
© 2025 McKesson Corporation
McKesson’s Oncology & Specialty Practices support cancer patients across their entire care journey while unlocking value for providers and biopharma.
McKesson’s Oncology & Specialty Practices support cancer patients across their entire care journey while unlocking value for providers and biopharma.
Disclaimer: Our businesses play distinct roles throughout different patient journeys. This oncology patient journey illustrates one approach to oncology patient care.
1
Discovery
Evidence Generation
Trial Design & Optimization
Criteria for Community Adoption
Site Selection & Activation
Treatment Dispensation & Monitoring
KOL Engagement
2
Clinical Development
Evidence Generation
Trial Design & Optimization
Criteria for Community Adoption
Treatment Dispensation & Monitoring
3
Launch
Go-to-Market & Contracting Strategies
Provider Education & Engagement
Market Access
Concerned, his doctor suspects something more serious and promptly refers Joe to a specialist within The US Oncology Network (The Network). The Network ensures patients like Joe receive care close to home.
In the quiet town of Waconia, Minnesota, Joe K. is living a peaceful life until a persistent cough and fatigue leads him to his primary care provider.
A Quiet Life Disrupted
fact
Ontada's real-world oncology data represents over 2.4 million cancer patient records available for research across more than 80 tumor types derived largely from community settings.
With Ontada, we help to identify targets for drug development prioritization utilizing a combined dataset, including clinical and multiomics data.
Developing a new drug requires an understanding of unmet needs in order to identify new targets and prioritize clinical development.
Patient Population Analysis
FACT
Ontada's real-world oncology data represents over 2.4 million cancer patient records available for research across more than 80 tumor types derived largely from community settings.
Through Ontada, Genospace and Sarah Canon Research Institute (SCRI), we offer robust data and analytics to support evidence-informed decisions.
Integrating real-world evidence (RWE) and traditional trial data into evidence strategies strengthens clinical development and product launch programs.
Evidence Generation
FACT
SCRI enrolls more than 3,100 patients in treatment clinical trials each year.
Visit McKesson GPOs
Our Unity and Onmark GPOs maximize contract savings for specialty practices.
About McKesson Unity and Onmark GPOs
McKesson Medical-Surgical
A single source for wholesale medical-surgical supplies, lab equipment, pharmaceuticals and more.
McKesson Third Party Logsitics
Ensures the life-saving therapies arrive safely, efficiently and on time.
McKesson Specialty Distribution
Helps specialty providers run successful businesses by clearing the path so they can focus on patient care.
Biologics by McKesson
Delivers personalized care as an independent specialty pharmacy.
InspiroGene by McKesson
Solves the complexities of cell and gene therapies.
McKesson Group Purchasing Strategies
Maximizes contract savings for specialty practices.
Clinical Research Services and Clinical Trial Solutions
Addresses the complexities of clinical trial logistics through drug access, pharmacy and distribution services.
CoverMyMeds
Focuses on overcoming barriers to medication access and affordability for patients throughout every step of their journey.
The US Oncology Network
Shapes the future of cancer care, close to home.
McKesson Compile
Helps biopharma companies develop and commercialize life-changing therapies through premier data and analytics.
Genospace
Innovates precision medicine to improve patient outcomes by enabling clinical trial matching.
Sarah Cannon Research Institute
Advances the field of cancer research through clinical trials.
Ontada
Accelerates life science research and provider channels to enable engagement and insights.
Integrating real-world evidence (RWE) and traditional trial data into evidence strategies strengthens clinical development and product launch programs.
Evidence Generation
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
FACT
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
FACT
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
We tailor trial design and protocol by conducting real-time feasibility analyses and simulations on unmet market needs through Ontada, SCRI and Genospace. Additionally, we enable clear insights into target patient populations with McKesson Compile.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
FACT
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
FACT
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
View Transcript
Enhancing Healthcare Through Data: McKesson Business Analytics
Read by Johnathan Longlastname, Job Title
Embedding real-world data into clinical trial design provides access to information from representative populations.
Trial Design & Optimization
FACT
McKesson Compile captures data on over six million healthcare professionals and more than 300 million patients.
Tracking adoption and analyzing prescriber data informs strategic marketing initiatives.
We provide detailed utilization reports through Ontada and identify key prescribers and influencers with data from McKesson Compile.
Adoption Monitoring & Influencer Identification
We facilitate continued provider engagement opportunities through Ontada, manage ongoing contracting with McKesson Group Purchasing Strategies (Unity and Onmark) and monitor value-based care programs with The Network.
Provider Insights
We offer a comprehensive suite of solutions that can shape the entire oncology drug development cycle.
Learn how we support discovery, clinical development, launch and growth strategies through our businesses as highlighted in this interactive journey.
1 Discovery
1 Discovery
1 Discovery
1 Discovery
4 Growth & Maturity
3 Launch
2 Clinical Development
1 Discovery
© 2025 McKesson Corporation
Businesses
One Oncology Patient’s Journey of Hope
Oncology Drug
Development Journey
McKesson’s Oncology & Specialty platform supports cancer patients across their entire care journey while unlocking value for providers and biopharma.
Joe K.'s Path to Remission
Disclaimer: Our businesses play distinct roles throughout different patient journeys. This oncology patient journey illustrates one approach to oncology patient care.
A Quiet Life Disrupted
In the quiet town of Waconia, Minnesota, Joe K. is living a peaceful life until a persistent cough and fatigue leads him to his primary care provider. Concerned, his doctor suspects something more serious and promptly refers Joe to a specialist within The US Oncology Network (The Network). The Network ensures patients like Joe receive care close to home.
MENU
The Network treats more than 1.4 million patients each year.
Behind the scenes, Joe’s physician leverages iKnowMed, Ontada’s oncology-specific electrical health record, to manage his referral and intake process, streamlining the workflow for his new care team.
A Community of Care
Joe’s physician continues to rely on iKnowMed to order genomic tests with ease and capture critical results to inform Joe’s diagnosis.
More than 2,600 oncology providers utilize Ontada’s point-of-care solutions including iKnowMed.
When the diagnosis arrives, it is lung cancer with a KRAS mutation. At the direction of Joe's physician, The Network takes charge of verifying Joe's insurance and provides him with essential education on precision medicine, giving him the tools he needs to understand his treatment options.
Facing the Diagnosis
Joe feels a wave of uncertainty, but The Network’s partnership with Sarah Cannon Research Institute (SCRI) offers a beacon of hope. SCRI's strong relationships with biopharma and their operational support opens doors to cutting-edge clinical trials, ensuring Joe has access to the latest advancements in cancer therapy.
Genospace plays a crucial role in precision patient identification, allowing Joe to be matched with the most suitable clinical trial.
Biologics by McKesson and McKesson Unity GPO will ensure Joe has affordable access to the comprehensive range of necessary specialty drugs and supplies. Whether it’s targeted therapies, immunotherapies or other cutting-edge treatments, we support healthcare providers in delivering the best possible care for their patients.
Joe is enrolled in a targeted therapy clinical trial. While The Network physician meticulously manages his care, Joe actively uses Ontada Health, the patient portal, to access his treatment schedule, view test results and communicate with his healthcare team.
Utilizing Clear Value Plus, a clinical decision-support tool, his physician identifies evidence-based treatment options ensuring Joe recieves the best standard of care.
A Chapter of Targeted Healing
The journey, however, does not end there. Joe's experience and the data collected throughout his treatment is invaluable to biopharma, contributing to the development of future therapies.
For instance, deidentified patient data is captured by McKesson Compile, which can help companies better understand and identify their target patient population, inform go-to-market strategies and more.
As the weeks pass, Joe responds positively to the treatment, and the day finally comes when he hears the word he has been longing for—remission.
Triumph and Transition
Joe's story is a testament to the power of collaboration, innovation and hope.
Together we aim to improve outcomes by accelerating drug development and clinical trial activation, ensuring therapies make their way to those who are counting on them closer to home, and delivering real-world data and evidence to advance cancer care.
FEATURED
Advancing Community Oncology Care
Read More
The US Oncology Network shapes the future of cancer care, close to home.
About The US Oncology Network
Visit The US Oncology Network
Visit Ontada
Ontada accelerates life science research and provider channels to enable engagement and insights.
About Ontada
Visit McKesson Group Purchasing Organizations
McKesson Group Purchasing Organizations maximize contract savings for specialty practices
About McKesson Group Purchasing Organizations
Visit Biologics by McKesson
Biologics by McKesson delivers personalized care as an independent specialty pharmacy.
About Biologics by McKesson
Visit McKesson Compile
McKesson Compile helps biopharma companies develop and commercialize life-changing therapies through premier data and analytics
About McKesson Compile
Businesses
One Oncology
Patient’s Journey
of Hope
Oncology Drug
Development Journey
The US Oncology Network
Shapes the future of cancer care, close to home.
Sarah Cannon Research Institute
Advances the field of cancer research through clinical trials.
Ontada
Accelerates life science research and provider channels to enable engagement and insights.
McKesson Specialty Distribution
Helps specialty providers run successful businesses by clearing the path so they can focus on patient care.
McKesson GPOs
Maximize contract savings for specialty practices.
McKesson Compile
Helps biopharma companies develop and commercialize life-changing therapies through premier data and analytics.
InspiroGene by McKesson
Solves the complexities of cell and gene therapies.
Genospace
Innovates precision medicine to improve patient outcomes by enabling clinical trial matching.
CoverMyMeds
Focuses on overcoming barriers to medication access and affordability for patients throughout every step of their journey.
Biologics by McKesson
Delivers personalized care as an independent specialty pharmacy.
CLOSE
Clinical Research Services and Clinical Trial Solutions
Addresses the complexities of clinical trial logistics through drug access, pharmacy and distribution services.
McKesson Third Party Logsitics
Ensures the life-saving therapies arrive safely, efficiently and on time.
© 2025 McKesson Corporation
VISIT McKESSON.COM
EXPLORE THE DRUG DEVELOPMENT JOURNEY
Disclaimer: Our businesses play distinct roles throughout different patient journeys. This oncology patient journey illustrates one approach to oncology patient care.
McKesson’s Oncology & Specialty Practices support cancer patients across their entire care journey while unlocking value for providers and biopharma.
Joe K.'s Path to Remission
A Quiet Life Disrupted
Concerned, his doctor suspects something more serious and promptly refers Joe to a specialist within The US Oncology Network (The Network). The Network ensures patients like Joe receive care close to home.
In the quiet town of Waconia, Minnesota, Joe K. is living a peaceful life until a persistent cough and fatigue leads him to his primary care provider.
Concerned, his doctor suspects something more serious and promptly refers Joe to a specialist within The US Oncology Network (The Network). The Network ensures patients like Joe receive care close to home.
In the quiet town of Waconia, Minnesota, Joe K. is living a peaceful life until a persistent cough and fatigue leads him to his primary care provider.
A Quiet Life Disrupted
The Network treats more than 1.4 million patients each year.
Behind the scenes, Joe’s provider leverages iKnowMed, Ontada’s award winning electronic medical record, to manage his referral and intake process, streamlining the workflow for his new care team.
A Community of Care
More than 2,600 oncology providers utilize Ontada’s point of care solutions including iKnowMed.
The Network takes charge of verifying Joe’s insurance and provides him with essential education on precision medicine, giving him the tools he needs to understand his treatment options.
SCRI's strong relationships with biopharma and their operational support opens doors to cutting-edge clinical trials, ensuring Joe has access to the latest advancements in cancer therapy.
Genospace plays a crucial role in precision patient identification, allowing Joe to be matched with the most suitable clinical trial.
When the diagnosis arrives, it is lung cancer with a KRAS mutation. Joe feels a wave of uncertainty, but The Network’s partnership with Sarah Cannon Research Institute (SCRI) offers a beacon of hope
Facing the Diagnosis
There are more than 1,300 research physicians across SCRI’s network.
Utilizing Clear Value Plus, his physician identifies the best therapy options. If Joe needs chemotherapy, then Biologics by McKesson, McKesson Medical-Surgical and McKesson Unity GPO will provide his physician with affordable access to the necessary specialty drugs and supplies.
A Chapter of Targeted Healing
McKesson’s Oncology & Specialty Practices support cancer patients across their entire care journey while unlocking value for providers and biopharma.
Biologics by McKesson offers more than 200 oncology and rare disease therapies.
McKesson Medical-Surgical
A single source for wholesale medical-surgical supplies, lab equipment, pharmaceuticals and more.
© 2025 McKesson Corporation
VISIT McKESSON.COM
EXPLORE THE PATIENT JOURNEY
Joe is enrolled in a targeted therapy clinical trial. The Network physician meticulously manages his care, utilizing Ontada Health to track his progress and outcomes.
© 2025 McKesson Corporation
Businesses
One Oncology Patient’s Journey of Hope
Oncology Drug
Development Journey
Visit Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) advances the field of cancer research through clinical trials.
About Sarah Cannon Research Institute
